AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,565 Cr | ₹2,387 Cr | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr |
What is the latest Revenue of AARTI DRUGS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,565 Cr |
| Mar2025 | ₹2,387 Cr |
| Mar2024 | ₹2,529 Cr |
| Mar2023 | ₹2,716 Cr |
| Mar2022 | ₹2,489 Cr |
How is Revenue of AARTI DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,565 Cr | 7.47 | |
| Mar2025 | ₹2,387 Cr | -5.60 | |
| Mar2024 | ₹2,529 Cr | -6.90 | |
| Mar2023 | ₹2,716 Cr | 9.14 | |
| Mar2022 | ₹2,489 Cr | - | |
Compare Revenue of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,414.6 Cr | -3.9% | -12.7% | -23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -3.9% |
-12.7% |
-23.3% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses